Page 116 - 2021 IDMT Digital

ACTINIC KERATOSIS
Introduction:
• 0DFXOHV DQG SDSXOHV RQ VXQ H[SRVHG DUHDV
• &RQVLGHUHG WR EH SUH PDOLJQDQW
o OHVLRQV SHU \HDU SURJUHVV LQWR VTXDPRXV FHOO FDUFLQRPD
Subjective:
• 6LJQV DQG 6\PSWRPV
o 0DFXOHV DQG SDSXOHV XVXDOO\ RI IDLU VNLQQHG LQGLYLGXDOV RQ VXQ H[SRVHG VNLQ
o )HHOV OLNH VDQGSDSHU DQG FDQ EH WHQGHU ZKHQ WRXFKHG
• )RFXVHG +LVWRU\
o )DPLO\ RU SHUVRQDO KLVWRU\ RI VNLQ FDQFHU
o 3HUVRQDO KLVWRU\ RI LQWHQVH SHHOLQJ VXQEXUQV
o 6XQVFUHHQ XVH
o &KDQJHV WR WKH OHVLRQ V $%&'( UXOH
Objective:
• 3K\VLFDO ([DP
o )XOO VNLQ H[DP
o $SSHDUDQFH VPDOO FP PDFXOHV RU SDSXOHV IOHVK FRORUHG SLQN
RU VOLJKWO\ K\SHUSLJPHQWHG
Assessment:
• 'LIIHUHQWLDO
o 0HODQRF\WLF QHYL QRUPDO PROHV VPDOO OHVLRQV ZLWK D ZHOO GHILQHG ERUGHU DQG
VLQJOH VKDGH RI SLJPHQW
o 6HERUUKHLF NHUDWRVLV EHQLJQ SODTXHV ZLWK D YHOYHW\ RU ZDUW\ VXUIDFH DSSHDU WR
EH VWXFN RQWR WKH VNLQ
o 6TXDPRXV FHOO FDUFLQRPD QRQ KHDOLQJ XOFHU RU ZDUW\ QRGXOH
o %DVDO FHOO FDUFLQRPD ZD[\ SHDUO\ WUDQVOXFHQW SDSXOH
o 0DOLJQDQW PHODQRPD $%&'( LUUHJXODULWLHV
Plan:
• 7UHDWPHQW OLTXLG QLWURJHQ
• 5HIHUUDO IRU SHUVLVWHQW OHVLRQ RU LI GLDJQRVLV XQFOHDU

Patient Education:
• $OZD\V XVH VXQVFUHHQ DQG VXQ SURWHFWLYH PHDVXUHV
• )ROORZ XS $FWLRQV
o 5HIHUUDO IRU SHUVLVWHQW OHVLRQV
o (QFRXUDJH FRPSOLDQFH ZLWK VSHFLDOW\ UHFRPPHQGDWLRQV
o 5HWXUQ IRU IXUWKHU HYDOXDWLRQ IRU DQ\ QHZ VXVSLFLRXV OHVLRQV
Preceptor Directive:
• Green Directive: Routine Review by Preceptor IAW AFI 44-103

[ 115 ]